Cargando…
Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway
Cholangiocarcinoma (CCA) is an aggressive tumor of the biliary epithelium with poor survival that shows limited response to conventional chemotherapy. Increased expression of glucosylceramide synthase (GCS) contributes to drug resistance and the progression of various cancers; the expression profile...
Autores principales: | Chueakwon, Piyasiri, Jatooratthawichot, Peeranat, Talabnin, Krajang, Ketudat Cairns, James R., Talabnin, Chutima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949529/ https://www.ncbi.nlm.nih.gov/pubmed/35330102 http://dx.doi.org/10.3390/life12030351 |
Ejemplares similares
-
RNF43 overexpression attenuates the Wnt/β-catenin signalling pathway to suppress tumour progression in cholangiocarcinoma
por: Pangestu, Norma Sainstika, et al.
Publicado: (2021) -
Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways
por: Khiaowichit, Juthamas, et al.
Publicado: (2022) -
Effect of Expression of Human Glucosylceramidase 2 Isoforms on Lipid Profiles in COS-7 Cells
por: Jatooratthawichot, Peeranat, et al.
Publicado: (2020) -
Increased expression of the high-mannose M6N2 and NeuAc3H3N3M3N2F tri-antennary N-glycans in cholangiocarcinoma
por: Talabnin, Krajang, et al.
Publicado: (2018) -
Ganglioside GM2: a potential biomarker for cholangiocarcinoma
por: Talabnin, Krajang, et al.
Publicado: (2020)